Humpa, Karen .

HRN: 07-62-17  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2022
CEFAZOLIN 1GM (VIAL)
09/21/2022
09/21/2022
IV
2g
LD
Preop Prophylaxis
Waiting Final Action 
09/21/2022
CEFTRIAXONE 1G (VIAL)
09/21/2022
09/28/2022
IV
1g
OD
S/P Pelvic Lap
Waiting Final Action 
09/21/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/21/2022
09/28/2022
IV
500mg
Q12
S/P Pelvic Lap
Waiting Final Action 
09/22/2022
DOXYCYCLINE 100MG (CAP)
09/22/2022
10/06/2022
ORAL
100 Mg
BID
Post Pelvic Lap; Sexually Transmitted Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: